Patent Assignment
Reel/Frame 057532/0424
Security Interest
Recorded: 2021-09-20
Pages: 10
Assignor
AZURITY PHARMACEUTICALS, INC.
Executed: 2021-09-20
Assignee
JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
IL1-1145/54/63, P.O. BOX 6026, CHICAGO, ILLINOIS, 60680-6026
Covered Properties
(39)
Compositions and Kits for Compounding Pharmaceuticals
Patent:
6,708,822 →
Application:
09/707,783 →
Container and Method for the Preparation, Storage and Dispensing of Compounded Suppositories
Container and Kit for the Preparation, Storage and Dispensing of Compounded Suppositories
Container and Kit for the Preparation, Storage and Dispensing of Compounded Suppositories
Composition and Method for Vancomycin Oral Liquid
Composition and Method for Vancomycin Oral Liquid
Container and Method for the Preparation, Storage and Dispensing of Compounded Suppositories
Composition and Method for Vancomycin Oral Liquid
Composition and Method for Vancomycin Oral Liquid
Composition and Method for Vancomycin Oral Liquid
Composition and Method for Vancomycin Oral Liquid
Composition and Method for Vancomycin Oral Liquid
Application:
16/988,387 →
Publication:
US US20210023002A1
Composition and Method for Vancomycin Oral Liquid
Application:
17/165,754 →
Publication:
US US20210169799A1
Composition and Method for Vancomycin Oral Liquid
Application:
17/077,969 →
Publication:
US US20210038515A1
Apparatus and Method for Filling Bulk Materials into a Container
Amlodipine Formulations
Amlodipine Formulations
Amlodipine Formulations
Amlodipine Formulations
Amlodipine Formulations
Amlodipine Formulations
Amlodipine Formulations
Composition and Method for Proton Pump Inhibitor Suspension
Compositions and Kits for Omeprazole Suspension
Patent:
10,751,333 →
Application:
16/513,604 →
Compositions and Kits for Omeprazole Suspension
Compositions and Kits for Omeprazole Suspension
Suspensions and Diluents for Metronidazole and Baclofen
Powder for Oral Suspension Containing Lamotrigine
Powder for oral suspension containing lamotrigine
Application:
16/974,343 →
Publication:
US US20210401748A1
Oral Pharmaceutical Composition Comprising Zonisamide and Process of Preparation Thereof
Enalapril Formulations
Enalapril Formulations
Enalapril Formulations
Enalapril Formulations
Enalapril Formulations
Enalapril Formulations
Enalapril Formulations
Enalapril Formulations
Patent:
9,669,008 →
Application:
15/081,603 →
Enalapril Formulations
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 11, 2012
From: MUNI, INDU; MUNI, GITA; PATEL, DILIP; MIONE, PETER
To: CUTISPHARMA, INC.
Reel/Frame 028528/0213 →
Security Agreement
Dec 16, 2014
From: CUTISPHARMA, INC.; RXEDESIGNEDMEDS, LLC; RXM THERAPEUTICS, LLC
To: SILICON VALLEY BANK
Reel/Frame 034648/0882 →
Assignment of Assignor's Interest
Jan 28, 2016
From: GANDHI, PREMAL; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 037603/0969 →
Assignment of Assignor's Interest
Jul 15, 2016
From: GANDHI, PREMAL; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 039169/0025 →
Assignment of Assignor's Interest
Feb 16, 2017
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CHRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 041268/0247 →
Corrective Assignment to Correct the the Misspelling of Inventor Name Previously Recorded at Reel: 041268 Frame: 0247. Assignor(S) Hereby Confirms the Assignment.
Mar 29, 2017
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 042108/0659 →
Assignment of Assignor's Interest
Nov 9, 2017
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 044079/0932 →
Security Interest
Mar 21, 2018
From: CUTISPHARMA, INC.
To: GOLDMAN SACHS SPECIALTY LENDING GROUP, L.P., AS COLLATERAL AGENT
Reel/Frame 045300/0385 →
Release of Security Interest
Mar 22, 2018
From: SILICON VALLEY BANK
To: CUTISPHARMA, INC.
Reel/Frame 045311/0168 →
Security Interest
May 17, 2019
From: CUTISPHARMA, INC.; SILVERGATE PHARMACEUTICALS, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 049209/0272 →
Release of Security Interest
May 17, 2019
From: GOLDMAN SACHS SPECIALTY LENDING GROUP, L.P., AS COLLATERAL AGENT
To: CUTISPHARMA, INC.
Reel/Frame 049212/0549 →
Assignment of Assignor's Interest
Oct 3, 2019
From: GANDHI, PREMAL; NAGLE, JAMES B.; HACKER, KEVIN
To: CUTISPHARMA, INC.
Reel/Frame 050612/0814 →
Assignment of Assignor's Interest
Oct 3, 2019
From: GANDHI, PREMAL; NAGLE, JAMES B.
To: CUTISPHARMA, INC.
Reel/Frame 050618/0329 →
Assignment of Assignor's Interest
Jan 3, 2020
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 051407/0224 →
Change of Name
Apr 9, 2020
From: CUTISPHARMA, INC.
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 052351/0891 →
Change of Name
Jun 19, 2020
From: CUTISPHARMA, INC.
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 052988/0389 →
Assignment of Assignor's Interest
Jun 19, 2020
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 052984/0939 →
Assignment of Assignor's Interest
Jul 30, 2020
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 053352/0207 →
Assignment of Assignor's Interest
Jul 30, 2020
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 053352/0143 →
Change of Name
Jul 31, 2020
From: CUTISPHARMA, INC.
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 053375/0771 →
Change of Name
Jul 31, 2020
From: CUTISPHARMA, INC.
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 053375/0748 →
Change of Name
Aug 20, 2020
From: CUTISPHARMA, INC.
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 053559/0737 →
Assignment of Assignor's Interest
Sep 28, 2020
From: BRAUER, SCOTT; MOSHER, GEROLD L.
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 053906/0057 →
Change of Name
Oct 20, 2020
From: CUTISPHARMA, INC.
To: AZURITY PHARMACEUTICALS, INC.
Reel/Frame 054142/0749 →
Assignment of Assignor's Interest
Oct 20, 2020
From: MUNI, INDU; MIONE, PETER; GANDHI, ANISA; LECHIARA, CRISTINA
To: CUTISPHARMA, INC.
Reel/Frame 054110/0417 →